Home › Funds › Encore Global Management, LP › BIIB

Encore Global Management, LP position in BIIB

BIOGEN INC · Health Care

Encore Global Management, LP reported holding 500 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$113K, representing 0.12% of its reported portfolio and ranking #48 among its reported holdings. Encore Global Management, LP has disclosed BIIB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)500 sh
Reported value held$112.94K
Portfolio Weight0.12%
First reportedQ1 2026
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Encore Global Management, LP's BIIB position evolved

Encore Global Management, LP first disclosed a stake in BIIB in Q1 2026 at 500 shares (US$92K). The position peaked in Q3 2026 at 500 shares, worth US$113K. Across 3 filings, Encore Global Management, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 500 shares valued at US$113K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 500 $91.67K New
Q2 2026 500 $108.03K Hold
Q3 2026 500 $112.94K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 21 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

All BIIB fund holders →

FAQ

How long has Encore Global Management, LP held BIIB?

Encore Global Management, LP has disclosed BIIB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Encore Global Management, LP's current position in BIIB?

As of Q3 2026, Encore Global Management, LP holds 500 shares of BIIB (BIOGEN INC), valued at $112.94K, representing 0.12% of its reported portfolio and ranking #48.

Has Encore Global Management, LP been buying or selling BIIB?

In the latest 13F filing (Q3 2026), Encore Global Management, LP held unchanged its position in BIIB. The position peaked in Q3 2026 at 500 shares.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.